Brainsway director reports initial BWAY equity holdings

Brainsway Ltd. director Karen Sarid filed an initial ownership report showing equity in both shares and options.

Rhea-AI Filing Summary

Brainsway Ltd. director Karen Sarid filed an initial ownership report showing equity in both shares and options. She holds 12,500 Ordinary Shares, a figure that includes 6,250 shares and 6,250 restricted stock units that vest quarterly until March 5, 2028. She also holds stock options over 25,000 Ordinary Shares, with the remaining 12,500 options vesting in equal quarterly installments through the same date and carrying an exercise price of NIS 11.17 per share. The Ordinary Shares may be represented by American Depositary Shares, each currently equal to one Ordinary Share.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider SARID KAREN

Role Director

Type	Security	Shares	Price	Value
holding	Stock Options (right to buy)	--	--	--
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Stock Options (right to buy) — 25,000 contracts (Direct); Ordinary Shares — 12,500 shares (Direct)

Footnotes (4)

1. F1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
2. F2. This figure includes: (i) 6,250 ordinary shares, and (ii) unvested restricted stock units ("RSUs") to receive 6,250 ordinary shares that vest quarterly until March 5, 2028, with each RSU representing a contingent right to receive one ordinary share.
3. F3. Stock options were granted on March 5, 2024, with the remaining options to purchase 12,500 ordinary shares vesting in equal quarterly installments until March 5, 2028.
4. F4. The exercise price is NIS 11.17 per share.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Karen Sarid’s Form 3 filing show for Brainsway Ltd. (BWAY)?

The Form 3 shows that director Karen Sarid holds 12,500 Ordinary Shares of Brainsway Ltd., including restricted stock units, and stock options over 25,000 Ordinary Shares that vest quarterly through March 5, 2028 at a set exercise price.

How many Brainsway (BWAY) shares and RSUs does Karen Sarid report owning?

Karen Sarid reports 12,500 Ordinary Shares, consisting of 6,250 actual shares and 6,250 restricted stock units. The RSUs vest quarterly until March 5, 2028, each giving a contingent right to receive one additional Ordinary Share upon vesting.

What stock options related to Brainsway (BWAY) does Karen Sarid hold?

She holds options to purchase 25,000 Ordinary Shares, granted March 5, 2024. The remaining 12,500 options vest in equal quarterly installments until March 5, 2028, with an exercise price of NIS 11.17 per share and expiration in 2034.

Are Brainsway (BWAY) Ordinary Shares linked to American Depositary Shares (ADSs)?

Yes. The filing notes that Brainsway’s Ordinary Shares may be represented by American Depositary Shares. Each ADS currently represents one Ordinary Share, providing U.S. investors an equivalent way to hold the same underlying equity interest.

Does Karen Sarid’s Form 3 for Brainsway (BWAY) show any recent share purchases or sales?

No. The Form 3 is an initial statement of beneficial ownership and lists Sarid’s existing holdings in Ordinary Shares, RSUs, and stock options. It does not report any open-market purchases or sales transactions in Brainsway securities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 04:04 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

SARID KAREN

(Last) (First) (Middle)

16 HARTUM STREET, RAD TOWER, 14TH FLOOR

HAR HAHOTZVIM

(Street)

JERUSALEM 9777516

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Brainsway Ltd. [ BWAY ]

3a. Foreign Trading Symbol
[BWAY]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares(1)(2)	12,500	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (right to buy)	(3)	03/05/2034	Ordinary Shares(1)	25,000	(4)	D

Explanation of Responses:

1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

2. This figure includes: (i) 6,250 ordinary shares, and (ii) unvested restricted stock units ("RSUs") to receive 6,250 ordinary shares that vest quarterly until March 5, 2028, with each RSU representing a contingent right to receive one ordinary share.

3. Stock options were granted on March 5, 2024, with the remaining options to purchase 12,500 ordinary shares vesting in equal quarterly installments until March 5, 2028.

4. The exercise price is NIS 11.17 per share.

	/s/ Karen Sarid	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)